Abstract Number: 1423 • 2014 ACR/ARHP Annual Meeting
Cardiovascular Risk Estimation in Rheumatoid Arthritis: What Is Missing in Traditional Risk Estimators?
Background/Purpose: Cardiovascular (CV) disease is one of the major causes of mortality in rheumatoid arthritis (RA). Although the CV risk in RA is well-recognized, detection…Abstract Number: 1422 • 2014 ACR/ARHP Annual Meeting
Demographic Differences in Health Related Information Technology Use Among Patients with Rheumatic Diseases
Background/Purpose: Use of the Internet and mobile technologies can be a valuable resource for patients with rheumatic diseases who are seeking health-related information, allowing patients…Abstract Number: 1441 • 2014 ACR/ARHP Annual Meeting
Accelerated Aging in DMARD and Treatment Naive Early Rheumatoid Arthritis Patients Measured By a Stem Cell Assay Is Associated with Increased LDL and Is Linked to Impaired Cardiopulmonary Function
Background/Purpose: The cardiovascular comorbidity seen in early treatment naive rheumatoid arthritis (RA) can be considered as an aspect of ´´accelerated aging``. Methods: We investigated cell…Abstract Number: 1440 • 2014 ACR/ARHP Annual Meeting
Asymptomatic Carotid Plaques in RA Patients Are Associated with Increased HDL Function
Background/Purpose Reverse cholesterol transport (RCT) is a major anti atherogenic function of high density lipoprotein cholesterol (HDL) and has been shown to be related to…Abstract Number: 1439 • 2014 ACR/ARHP Annual Meeting
Miscarriage in Rheumatoid Arthritis – Association with Disease Characteristics and Medication Use
Background/Purpose – The chance of miscarriage is increased after the diagnosis of rheumatoid arthritis (RA). The association of miscarriage with RA disease activity or anti-rheumatic…Abstract Number: 1438 • 2014 ACR/ARHP Annual Meeting
Association Between Chronic Inflammatory Conditions and Anti Cyclic Citrullinated Peptide Antibodies in Patients with Early Rheumatoid Arthritis
Background/Purpose : Increased citrullination process and anti–CCP production are not restricted to rheumatoid arthritis (RA). Other inflammatory processes could develop citrullinated proteins which may contribute…Abstract Number: 1437 • 2014 ACR/ARHP Annual Meeting
Cholesterol Efflux Capacity of HDL and Coronary Atherosclerosis in Rheumatoid Arthritis
Background/Purpose: Cardiovascular (CV) risk is increased in patients with rheumatoid arthritis (RA), but not fully explained by traditional risk factors such as LDL and HDL…Abstract Number: 1436 • 2014 ACR/ARHP Annual Meeting
Impact of Depression on Clinical and Social Outcomes in Patients with Rheumatoid Arthritis: Comparative Study in Germany and Brazil
Background/Purpose Rheumatoid Arthritis (RA) can be associated with psychological disorders and especially depression. About 13 – 20 % of patients have clinical significant depression. It…Abstract Number: 1434 • 2014 ACR/ARHP Annual Meeting
The Longitudinal Association Between Inflammation and Blood Pressure in Rheumatoid Arthritis
Background/Purpose Inflammation is hypothesized to have direct effects on arterial endothelial and vasomotor function, functions which regulate blood pressure (BP). While inflammation has been implicated…Abstract Number: 1435 • 2014 ACR/ARHP Annual Meeting
Changes in the Types and Prognoses of Infections Complicated in RA Patients during the Last 15 Years, in Japan.
[Background/Purpose ] Infliximab was introduced in 2002 as the first biological DMARD (bDMARD) in Japan. Currently, 5 TNF inhibitors, tocilizumab, and abatacept are available. Tacrolimus…Abstract Number: 1433 • 2014 ACR/ARHP Annual Meeting
Clinical Characterization of Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease
Background/Purpose Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a common manifestation of rheumatoid lung disease. Subclinical RA-ILD is most commonly identified on HRCT imaging. In…Abstract Number: 1432 • 2014 ACR/ARHP Annual Meeting
Mortality Ratio of Rheumatoid Arthritis Under Biological Treatment
Mortality Ratio of Rheumatoid Arthritis Under Biological Treatment: HUR-BIO real life results.Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease, which, in many patients, leads…Abstract Number: 1431 • 2014 ACR/ARHP Annual Meeting
Influence of Radiographic Joint Damage in Mortality Risk in a Cohort of Rheumatoid Arthritis Patients: A 20 Years Survival Study
Background/Purpose Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with increased mortality and reduced life expectancy compared with the general population. This mortality gap…Abstract Number: 1430 • 2014 ACR/ARHP Annual Meeting
IMPACT of Initiative to Control Cardiovascular Risk Factors in Collaboration with LOCAL Doctors in Patients with Rheumatoid Arthritis
Background/Purpose: Rheumatoid arthritis (RA) is associated with cardiovascular risk (CVR) with an increased prevalence of cardiovascular events and cardiovascular mortality than the general population. Good…Abstract Number: 1421 • 2014 ACR/ARHP Annual Meeting
Preclinical Interstitial Lung Disease in Early Rheumatoid Arthritis
Background/Purpose: Early detection and treatment of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) may ameliorate disease progression. The objective of the present…
ACR Meeting Abstracts